Delivery Order SPE2DB22D3301-SPE2DB26FX4AL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This is a firm fixed-price contract with a ceiling value of $2,349.10 and an ultimate completion date of June 27, 2025. The contract is not set-aside and represents a competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a $5,213.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.88 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. This is a competitively awarded, firm fixed-price contract with no set-aside designation and a ceiling value of $11,438.76. The delivery order is scheduled for completion by October 31, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a $9,667.42 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract utilizes firm fixed price pricing with a completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this delivery order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. This competitively awarded, non-set-aside contract has a ceiling value of $2,111.38 and a delivery deadline of August 4, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The contract utilizes firm fixed pricing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4ALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a ceiling value of $20,183.30. This competitively awarded, firm fixed-price delivery order represents a single-award transaction with an ultimate completion date of October 30, 2025. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a prime contractor under the comprehensive DLA pharmaceutical support vehicle, the company supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Ferumoxytol, an iron replacement therapy commonly used in military and veteran healthcare settings, exemplifies AmerisourceBergen's ongoing role in supplying specialized medications through the DLA's medical procurement framework. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 10/29/25 |